EUVIMEDEUVIMED entdecken
Crossref

Exosome Platform with Three-in-One Functionality of mRNA Therapy, Immune Checkpoint Blockade, and Mild Photothermal Therapy for the Treatment of Triple-Negative Breast Cancer

Wenwen Sun, Shiyun Huang, Zhihong Sun, Qi Zhao, Jie Li, Baoyu Wen, Jie Liu, Guanjun Deng, Chengming Sun iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.4c17804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Wenwen Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Shandong Provincial Hospital, Shandong University, Jinan 250021, P. R. China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Exosomes, Photothermal Therapy, RNA, Messenger. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Yantai Science and Technology Bureau, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsExosomesPhotothermal TherapyRNA, MessengerImmune Checkpoint InhibitorsHumansFemaleCell Line, TumorMiceAnimalsNanoparticlesInterleukin-2Tumor MicroenvironmentCell Proliferation

Stichwörter der Autor:innen

IL2 mRNAexosomesimmune checkpoint blockadelipid nanoparticlemild photothermal therapytriple-negative breast cancer

Substanzen

RNA, MessengerImmune Checkpoint InhibitorsInterleukin-2

Autor:innen und Institutionen

  • Shandong Provincial Hospital, Shandong University, Jinan 250021, P. R. China.
  • Yantai Yuhuangding Hospital, Yantai 264000, P. R. China.
  • School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, P. R. China.

ORCID-Profile: Chengming Sun

Förderung

  • Yantai Science and Technology Bureau
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Shenzhen city
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Sun, W., Huang, S., Sun, Z., Zhao, Q., Li, J., Wen, B., Liu, J., Deng, G., & Sun, C. (2025). Exosome Platform with Three-in-One Functionality of mRNA Therapy, Immune Checkpoint Blockade, and Mild Photothermal Therapy for the Treatment of Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c17804

Vancouver

Sun W, Huang S, Sun Z, Zhao Q, Li J, Wen B, et al. Exosome Platform with Three-in-One Functionality of mRNA Therapy, Immune Checkpoint Blockade, and Mild Photothermal Therapy for the Treatment of Triple-Negative Breast Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c17804

BibTeX
@article{Sun2025,
  author = {Sun, Wenwen and Huang, Shiyun and Sun, Zhihong and Zhao, Qi and Li, Jie and Wen, Baoyu and Liu, Jie and Deng, Guanjun and Sun, Chengming},
  title = {Exosome Platform with Three-in-One Functionality of mRNA Therapy, Immune Checkpoint Blockade, and Mild Photothermal Therapy for the Treatment of Triple-Negative Breast Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.4c17804}
}
Kostenlos starten →